According to Report Ocean, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at a CAGR of ~$% between 2022-2028 owing to rise in cases of UTIs, technological advancements ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Most important note is- surgeries for benign enlargement removes only the center part of the prostate to clear the ...

Raymond James has recently reduced Patterson-UTI Energy Inc (PTEN) stock to Mkt Perform rating, as announced on January 6, 2025, according to Finviz. Earlier, on December 13, 2024, Goldman had raised ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Millions of Brits can skip the GP queue this winter and head straight to their local pharmacist. Amid warnings a ‘quad-emic’ ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

As winter pressures and admissions with serious cases of flu mount in hospitals in Birmingham and the Black Country, ...

Prostate is a disease that occurs in men, if it is not treated on time, it can increase your problems. Know from Swami Ramdes ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...